Table 2.
Sampler | HRG | ICRG | Common human CpGs (%) | |||||
---|---|---|---|---|---|---|---|---|
Alignment efficiency (%) | n. of human CpGsa | Alignment efficiency (%) | Reads mapped to the human genome (%) | Reads mapped to the mouse genome (%) | n. of human CpGsa | n. of moue CpGsa | ||
Case_1_Normal | 72.2 | 2,317,726 | 72.2 | 99.9 | 0.1 | 2,315,989 | 102 | 99.9 |
Case_1_Tumuor | 74.1 | 2,676,050 | 74.1 | 99.9 | 0.1 | 2,674,961 | 119 | 99.9 |
Case_1_PDTX3 | 71.5 | 3,560,299 | 73.8 | 96.8 | 3.2 | 3,556,996 | 223,997 | 99.9 |
Case_2_Normal | 70.6 | 1,893,234 | 70.6 | 99.9 | 0.1 | 1,891,949 | 60 | 99.9 |
Case_2_Tumuor | 71.2 | 2,071,412 | 72.1 | 98.8 | 1.2 | 2,070,098 | 452 | 99.9 |
Case_2_PDTX1 | 68.5 | 2,132,270 | 73.4 | 93.2 | 6.8 | 2,130,231 | 90,072 | 99.8 |
Case_3_PDTX2 | 67.4 | 2,620,064 | 70.8 | 95.2 | 4.8 | 2,617,504 | 99,418 | 99.8 |
Case_3_PDTX3 | 54.7 | 1,623,532 | 71.0 | 76.9 | 23.1 | 1,620,101 | 339,859 | 99.7 |
Case_4_PDTX1 | 73.1 | 2,812,733 | 75.0 | 97.4 | 2.6 | 2,811,314 | 47,455 | 99.9 |
Case_4_PDTX2 | 69.1 | 1,503,423 | 72.3 | 95.6 | 4.4 | 1,501,890 | 13,819 | 99.8 |
Case_4_PDTX3 | 71.1 | 1,468,861 | 74.0 | 96.1 | 3.9 | 1,467,659 | 24,082 | 99.9 |
Case_4_PDTX5 | 69.2 | 3,185,468 | 73.5 | 94.0 | 6.0 | 3,182,452 | 264,898 | 99.9 |
Case_5_Tumuor | 72.8 | 3,004,752 | 72.8 | 99.9 | 0.1 | 3,003,290 | 87 | 99.9 |
Case_5_PDTX3 | 65.8 | 2,066,808 | 70.6 | 93.0 | 7.0 | 2,064,469 | 179,031 | 99.8 |
acoverage > 5